Planet Labs PBC Files Amendment No. 1 to 2026 Annual Report: Key Details for Investors

Planet Labs PBC (NYSE: PL) has filed Amendment No. 1 (Form 10-K/A) to its Annual Report for the fiscal year ended January 31, 2026. This amendment introduces important updates and corrections to the company’s previous filing and includes disclosures that shareholders and potential investors should be aware of.

Key Points from the Amendment

• Purpose of the Amendment: The amendment was filed to:
  1. Add disclosures of Rule 10b5-1 trading arrangements entered into during the last quarter by directors Ita Brennan, Kristen Robinson, and Gen. John W. Raymond. These were omitted from the original report.
  2. Include Exhibit 97.1, the “Planet Labs PBC Policy For Recovery of Erroneously Awarded Compensation,” which was also inadvertently omitted previously.
• No Restatement of Financials: The amendment does not update, amend, or restate any of the company’s financial statements or previously reported financial results.
• Limited Scope: Other than the specific items mentioned above, all information in the original filing remains unchanged and reflects disclosures made as of March 23, 2026.
• New Certifications: As required by SEC Rule 12b-15, new certifications by the company’s CEO and CFO have been filed with this amendment, but no new Section 906 certifications are provided since no financial statements are included in this filing.

Material Disclosures & Potential Price-Sensitive Information

• 10b5-1 Trading Plans by Directors:
  • The disclosure of new or revised Rule 10b5-1 trading plans by directors is a regulatory requirement under recent SEC rules. For transparency, Planet Labs PBC has now disclosed that during the three months ended January 31, 2026, directors Ita Brennan, Kristen Robinson, and Gen. John W. Raymond established such plans.
  • Why This Matters: Rule 10b5-1 trading plans, when adopted, allow executives and directors to sell shares at predetermined times, potentially regardless of any subsequent non-public information. Disclosure of these plans is important as it informs investors about possible future insider transactions, which can affect market sentiment and the company’s share price.
• Recovery Policy for Erroneous Compensation:
  • Exhibit 97.1, the “Policy For Recovery of Erroneously Awarded Compensation,” is now included. This policy, commonly referred to as a “clawback” policy, outlines procedures for the recovery of incentive-based compensation in the event of accounting restatements due to material noncompliance with financial reporting requirements.
  • Why This Matters: The addition of a clawback policy aligns Planet Labs with recent SEC and stock exchange listing requirements, enhancing governance and investor protection. Investors often view the presence of a robust recovery policy as a positive for corporate oversight and risk management.
• No Financial Restatements or Errors:
  • The amendment explicitly states that there are no corrections of previously issued financial statements or restatements. This is important for shareholders as it confirms the integrity of prior financial disclosures.

Other Notable Information

• Filing Status: The company continues to be classified as a non-accelerated filer and a smaller reporting company. It is not an emerging growth company.
• Internal Controls: The company has filed a report and attestation regarding the effectiveness of its internal control over financial reporting by its independent registered public accounting firm, as required under Section 404(b) of the Sarbanes-Oxley Act.
• Proxy Statement Incorporation: Portions of the company’s 2026 proxy statement are incorporated by reference into Part III of the Form 10-K/A.

What Should Shareholders Watch?

• Potential Insider Share Sales: The disclosure of 10b5-1 trading plans by key directors could lead to future insider sales. While these plans are meant to avoid the appearance of insider trading, significant planned sales can occasionally affect investor confidence and share price, especially if not well understood by the market.
• Governance Enhancements: The publication of a clawback policy is a positive development, signaling strong corporate governance and accountability, which can bolster investor trust in the long term.
• Regulatory Compliance: The amendment demonstrates Planet Labs’ commitment to full compliance with SEC disclosure requirements. No adverse findings or restatements have been made.

Conclusion

While the amendment does not introduce changes to financial results, the formal disclosure of directors’ trading plans and the implementation of a compensation recovery policy are both significant governance events. Investors should monitor future filings for any updates on insider transactions under the disclosed 10b5-1 plans, as these could impact market perceptions and, potentially, the share price.

Disclaimer: This article is based on information contained in Planet Labs PBC’s Form 10-K/A as filed with the U.S. Securities and Exchange Commission. It is intended for informational purposes only and does not constitute investment advice. Investors should consult their financial advisers and review the official filings for complete details before making any investment decisions.

View Planet Labs PBC Historical chart here